Overview
Valued at
~$2.07 billion in 2023, the surgical endoscopic ENT devices market is projected to
reach
~$2.49 billion by 2028, increasing at a
CAGR of 3.8% over the 2023-2028
forecast period. This Market Snapshot is part of
LSI’s Market Intelligence platform, your
one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and
deal-tracking, curated insights, and more.
This Market Snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic
devices for
ENT
surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose,
and throat.
Products included within the scope of this analysis include:
ENT endoscopic surgical instruments
Balloon sinus and dilation catheters
Rigid endoscopes and bronchoscopes
This Market Snapshot is intended to provide a high-level overview of the global market for surgical endoscopic
ENT devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Surgical Endoscopic ENT Devices Market Snapshot Summary
| Snapshot Aspect |
Data and Details |
| Base Year for Estimate |
2023 |
| Forecast Period |
2023 - 2028 |
| Market Size in 2023 |
$2.07 billion |
| CAGR |
3.8% |
| Projected Market Size in 2028 |
$2.49 billion |
Surgical Endoscopic ENT Devices Market Insights
The surgical endoscopic ENT devices market benefits from several factors, including demographic shifts and
increased access to outpatient care, making ENT procedures more accessible. This has contributed to the rising
demand for endoscopic devices used in surgeries, such as rigid and flexible endoscopes,
electrosurgical
instruments, and ENT forceps. Major suppliers like Olympus and KARL STORZ dominate the market. However,
newer entrants, such as Intuitive Surgical with robotic devices for ENT applications and Entellus
Medical/Stryker with advanced sinus dilatation tools, are expanding the market scope by offering innovative
solutions for office-based procedures.
Despite the promising growth in unit volumes, the market faces challenges due to downward pressure on pricing,
particularly for balloon dilatation devices and other products. This is compounded by reimbursement pressures,
which are expected to keep the dollar volume growth at a low, single-digit rate. Companies focusing on
cost-effective solutions and innovative technology will be well-positioned to capture market share in the
growing ENT endoscopic surgery space as the market evolves.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the surgical endoscopic ENT
devices market. This includes estimated market revenue and market share for key players, such as Olympus, KARL
STORZ, and Entellus Medical/Stryker.
Select Market Events
|
Company
|
Date
|
Event Type
|
Event
|
|
|
5/2024
|
Product Launch
|
Olympus announced the availability of its new DVM-B2 Digital Video Monitor, which can be
used with single-use endoscopes for bronchoscopy and ENT.
|
|
|
7/2023
|
M&A
|
Karl Storz announced its acquisition of AventaMed, strengthening its ENT portfolio.
|
Key Companies Covered
Acclarent/Integra LifeSciences
ConMed
Entellus Medical/Styker
Intuitive Surgical
Johnson & Johnson
KARL STORZ
Olympus
PENTAX Medical
Richard Wolf
